| Cell line name |
KlHe |
|---|
| Accession |
CVCL_E6XG |
|---|
| Resource Identification Initiative |
To cite this cell line use: KlHe (RRID:CVCL_E6XG) |
|---|
| Comments |
Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. |
|---|
| HLA typing |
Source: PubMed=12836015
| Class I | | HLA-A | A*01,24 | | HLA-B | B*07,37 | | Class II | | HLA-DQ | DQB1*03:01,06:02 | | HLA-DR | DRB1*11:04:01,15:01:01 |
|
|---|
| Disease |
Ovarian carcinoma (NCIt: C4908) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=12836015; DOI=10.1007/s00432-003-0445-7
Kayser S., Watermann I., Rentzsch C., Weinschenk T., Wallwiener D., Guckel B.
Tumor-associated antigen profiling in breast and ovarian cancer: mRNA, protein or T cell recognition?
J. Cancer Res. Clin. Oncol. 129:397-409(2003) |
|---|
| Entry history |
|---|
| Entry creation | 10-Apr-2025 |
|---|
| Last entry update | 10-Apr-2025 |
|---|
| Version number | 1 |
|---|
